Cholera Toxin Indirectly Activates Human Monocyte-Derived Dendritic Cells In Vitro through the Production of Soluble Factors, Including Prostaglandin E2and Nitric Oxide
Open Access
- 1 January 2006
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 13 (1) , 106-115
- https://doi.org/10.1128/cvi.13.1.106-115.2006
Abstract
Cholera toxin (CT) is a potent adjuvant that activates dendritic cells (DC) by increasing intracellular cyclic AMP (cAMP) levels. In vivo and in vitro, very small amounts of CT induce potent adjuvant effects and activate DC. We hypothesized that DC intoxicated by CT may release factors that enhance their own maturation and induce the maturation of toxin-free bystander DC. Through the use of mixed cultures and transwell cultures, we found that human monocyte-derived DC (MDDC) pulsed with CT or other cAMP-elevating agonists induce the maturation of bystander DC. Many DC agonists including CT increase the production of prostaglandin E2(PGE2) and nitric oxide (NO). For this reason, we determined whether the actions of PGE2or NO are involved in the maturation of MDDC induced by CT or dibutyryl-cAMP (d-cAMP). We found that blocking the production of PGE2or blocking prostaglandin receptors inhibited MDDC maturation induced by CT and d-cAMP. Likewise, sequestering NO or blocking the downstream actions of NO resulted in the inhibition of MDDC maturation induced by CT and d-cAMP. These results indicate that endogenously produced factors including PGE2and NO contribute to the maturation of DC induced by CT and that these factors participate in bystander DC maturation. The results of this study may help explain why bacterial toxins that elevate cAMP are such potent adjuvants.Keywords
This publication has 54 references indexed in Scilit:
- Calcium Signaling through Phospholipase C Activates Dendritic Cells To Mature and Is Necessary for the Activation and Maturation of Dendritic Cells Induced by Diverse AgonistsClinical and Vaccine Immunology, 2004
- An Enzymatically Active A Domain Is Required for Cholera-Like Enterotoxins To Induce a Long-Lived Blockade on the Induction of Oral Tolerance: New Method for Screening Mucosal AdjuvantsInfection and Immunity, 2003
- Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxinVaccine, 2003
- Guanylate cyclase and the ⋅NO/cGMP signaling pathwayBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1999
- Development of a Fluorescent Indicator for Nitric Oxide Based on the Fluorescein Chromophore.CHEMICAL & PHARMACEUTICAL BULLETIN, 1998
- Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin‐1 secretionFEBS Letters, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophilsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Size and Structure of the Cholera Toxin Molecule and Its SubunitsThe Journal of Infectious Diseases, 1976
- Cholera Toxin: Interaction of Subunits with Ganglioside G M1Science, 1974